This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
B-cell lymphoma proteins 3D structures
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
*Bcl-xL (Bcl-2-like protein 1) | *Bcl-xL (Bcl-2-like protein 1) | ||
| - | **[[1maz]], [[1r2d]], [[2b48]], [[4ppi]] – hBcl-xL – human<br /> | + | **[[1maz]], [[1r2d]], [[2b48]], [[4ppi]], [[7ca4]] – hBcl-xL – human<br /> |
**[[1r2e]], [[1r2g]], [[1r2h]], [[1r2i]], [[3cva]] - hBcl-xL (mutant)<br /> | **[[1r2e]], [[1r2g]], [[1r2h]], [[1r2i]], [[3cva]] - hBcl-xL (mutant)<br /> | ||
**[[2lpc]], [[2m03]], [[2me8]], [[2me9]], [[1lxl]] - hBcl-xL – NMR<br /> | **[[2lpc]], [[2m03]], [[2me8]], [[2me9]], [[1lxl]] - hBcl-xL – NMR<br /> | ||
**[[6bf2]] - hBcl-xL (mutant) – NMR<br /> | **[[6bf2]] - hBcl-xL (mutant) – NMR<br /> | ||
| + | **[[6x7i]] - hBcl-xL C terminal - NMR<br /> | ||
**[[3fdm]] - hBcl-xL + α/β peptide foldamer<br /> | **[[3fdm]] - hBcl-xL + α/β peptide foldamer<br /> | ||
**[[2mej]] - hBcl-xL + p53 - NMR<br /> | **[[2mej]] - hBcl-xL + p53 - NMR<br /> | ||
| + | **[[6lhd]] - hBcl-xL/p53 <br /> | ||
| + | **[[1ysg]], [[3sp7]], [[3spf]], [[3wiz]], [[4tuh]], [[3zln]], [[3zk6]], [[3zlo]], [[3zlr]], [[4c52]], [[4c5d]], [[2yxj]], [[4qnq]], [[4qvx]], [[6rnu]], [[6vwc]], [[7jgv]], [[7jgw]] - hBcl-xL + inhibitor<br /> | ||
**[[3inq]] - hBcl-xL (mutant) + inhibitor<br /> | **[[3inq]] - hBcl-xL (mutant) + inhibitor<br /> | ||
| - | **[[1ysg]], [[3sp7]], [[3spf]], [[3wiz]], [[4tuh]], [[3zln]], [[3zk6]], [[3zlo]], [[3zlr]], [[4c52]], [[4c5d]], [[2yxj]], [[4qnq]], [[4qvx]] - hBcl-xL + inhibitor<br /> | ||
**[[2w3l]] – hBcl-xL + quinoline derivative<br /> | **[[2w3l]] – hBcl-xL + quinoline derivative<br /> | ||
**[[2o1y]], [[2o2m]], [[2o2n]], [[1ysi]], [[1ysn]], [[2o21]], [[2o22]], [[2o2f]] - hBcl-xL + sulfonamide derivative – NMR<br /> | **[[2o1y]], [[2o2m]], [[2o2n]], [[1ysi]], [[1ysn]], [[2o21]], [[2o22]], [[2o2f]] - hBcl-xL + sulfonamide derivative – NMR<br /> | ||
**[[3qkd]], [[4ehr]] - hBcl-xL + sulfonamide derivative<br /> | **[[3qkd]], [[4ehr]] - hBcl-xL + sulfonamide derivative<br /> | ||
**[[2pon]] - hBcl-xL + Beclin-1 residues 1-23 - NMR<br /> | **[[2pon]] - hBcl-xL + Beclin-1 residues 1-23 - NMR<br /> | ||
| + | **[[6zhc]] - hBcl-xL + elongin B + elongin C + VHL<br /> | ||
| + | **[[6ijq]] - hBcl-xL + p73 peptide - NMR<br /> | ||
| + | **[[6yli]] - hBcl-xL + TRBak peptide <br /> | ||
| + | **[[6hjl]], [[6st2]], [[6stj]] – hBcl-2-L-1 + affirmer<br /> | ||
**[[3ihc]], [[3iih]], [[1pq0]] – mBcl-xL residues 1-196 – mouse<br /> | **[[3ihc]], [[3iih]], [[1pq0]] – mBcl-xL residues 1-196 – mouse<br /> | ||
**[[3ihd]], [[3ihe]], [[3ihf]], [[3iig]], [[3ilb]], [[3ilc]] - mBcl-xL residues 1-196 (mutant) <br /> | **[[3ihd]], [[3ihe]], [[3ihf]], [[3iig]], [[3ilb]], [[3ilc]] - mBcl-xL residues 1-196 (mutant) <br /> | ||
| Line 23: | Line 29: | ||
**[[1pq1]], [[5c3g]] - mBcl-xL residues 1-196 + BIM peptide<br /> | **[[1pq1]], [[5c3g]] - mBcl-xL residues 1-196 + BIM peptide<br /> | ||
**[[1af3]] - rBcl-xL soluble domain<br /> | **[[1af3]] - rBcl-xL soluble domain<br /> | ||
| + | **[[6wh0]] - Bcl-xL + BAX peptide - hydra<br /> | ||
**[[1bxl]] - Bcl-xL + Bak peptide – Escherichia coli – NMR<br /> | **[[1bxl]] - Bcl-xL + Bak peptide – Escherichia coli – NMR<br /> | ||
**[[5twa]] - Bcl-xL + Bak peptide – sponge<br /> | **[[5twa]] - Bcl-xL + Bak peptide – sponge<br /> | ||
| Line 34: | Line 41: | ||
**[[5b1z]] - hBcl-xL + BHX BH3 domain<br /> | **[[5b1z]] - hBcl-xL + BHX BH3 domain<br /> | ||
**[[4z9v]] - hBcl-xL + TCTP BH3 domain<br /> | **[[4z9v]] - hBcl-xL + TCTP BH3 domain<br /> | ||
| - | **[[6dcn]] - hBcl-xL + Beclin-1 BH3 domain<br /> | + | **[[6dcn]], [[6dco]] - hBcl-xL + Beclin-1 BH3 domain<br /> |
**[[2p1l]] - hBcl-xL (mutant) + Beclin-1 BH3 domain<br /> | **[[2p1l]] - hBcl-xL (mutant) + Beclin-1 BH3 domain<br /> | ||
**[[2yq6]], [[4qvf]], [[4yk9]], [[3fdl]], [[5agx]], [[4yj4]], [[3io8]], [[2yq7]], [[5vx3]], [[5agw]] - hBcl-xL + BIM BH3 domain<br /> | **[[2yq6]], [[4qvf]], [[4yk9]], [[3fdl]], [[5agx]], [[4yj4]], [[3io8]], [[2yq7]], [[5vx3]], [[5agw]] - hBcl-xL + BIM BH3 domain<br /> | ||
| - | **[[2yj1]], [[4bpk]], [[4hnj]] - hBcl-xL + | + | **[[2yj1]], [[4bpk]], [[4hnj]] - hBcl-xL + alpha-beta-puma BH3 domain<br /> |
| - | **[[4a1u]], [[4a1w]] - hBcl-xL + | + | **[[4a1u]], [[4a1w]] - hBcl-xL + alpha-beta-foldamer BH3 domain<br /> |
**[[3r85]] - hBcl-xL + heme-binding protein BH3 peptide<br /> | **[[3r85]] - hBcl-xL + heme-binding protein BH3 peptide<br /> | ||
| - | **[[2lp8]] – hBcl-xL + Bcl-2 homologous antagonist/killer BH3 peptide - NMR<br /> | + | **[[2lp8]] – hBcl-xL + Bcl-2 homologous antagonist/killer BH3 peptide- NMR<br /> |
**[[2m04]] – hBcl-xL (mutant) + Bcl-2 binding component 3 BH3 peptide - NMR<br /> | **[[2m04]] – hBcl-xL (mutant) + Bcl-2 binding component 3 BH3 peptide - NMR<br /> | ||
**[[5wos]] - Bcl-xL + hBIM BH3 domain – canarypox virus<br /> | **[[5wos]] - Bcl-xL + hBIM BH3 domain – canarypox virus<br /> | ||
**[[5tzp]] - fpvBcl-xL + BIK BH3 domain – fowlpox virus<br /> | **[[5tzp]] - fpvBcl-xL + BIK BH3 domain – fowlpox virus<br /> | ||
**[[5tzq]] - fpvBcl-xL + Bmf BH3 domain <br /> | **[[5tzq]] - fpvBcl-xL + Bmf BH3 domain <br /> | ||
| + | **[[6yld]] - Bcl-xL + Bak BH3 domain - Trichoplax<br /> | ||
| - | *Bcl-2 | + | *Bcl-2 or apoptosis regulator Bcl-2 |
**[[1gjh]], [[1g5m]] – hBcl-2<br /> | **[[1gjh]], [[1g5m]] – hBcl-2<br /> | ||
| - | **[[4aq3]], [[4man]], [[5jsn]], [[4ieh]] – hBcl-2 + inhibitor<br /> | + | **[[4aq3]], [[4man]], [[5jsn]], [[4ieh]], [[6gl8]], [[6qgg]], [[6qgj]], [[6qgk]], [[7jmt]] – hBcl-2 + inhibitor<br /> |
| - | **[[4lvt]], [[4lxd]] – hBcl-2 (mutant) + inhibitor<br /> | + | **[[4lvt]], [[4lxd]], [[6o0k]], [[6o0m]], [[6o0o]], [[6o0p]] – hBcl-2 (mutant) + inhibitor<br /> |
| + | **[[7lhb]] – hBcl-2 + drug<br /> | ||
**[[5fcg]] – hBcl-2 (mutant) + HBX BH3 domain<br /> | **[[5fcg]] – hBcl-2 (mutant) + HBX BH3 domain<br /> | ||
**[[2xa0]] – hBcl-2 residues 1-207 + apoptosis regulator Bax BH3 domain<br /> | **[[2xa0]] – hBcl-2 residues 1-207 + apoptosis regulator Bax BH3 domain<br /> | ||
| - | **[[2o21]], [[2o22]], [[2o2f]], [[1ysw]] - hBcl-2 + sulfonamide derivative – NMR | + | **[[2o21]], [[2o22]], [[2o2f]], [[1ysw]] - hBcl-2 + sulfonamide derivative – NMR<br /> |
| + | **[[6v4m]] – Bcl-2 – Trichuris suis<br /> | ||
*Bcl-2-related protein A1 (Bfl-1) | *Bcl-2-related protein A1 (Bfl-1) | ||
| + | **[[6vo4]] - hBcl-2A1<br /> | ||
**[[5whi]] - hBcl-2A1 (mutant) <br /> | **[[5whi]] - hBcl-2A1 (mutant) <br /> | ||
| - | **[[2vm6]] | + | **[[2vm6]], [[3mqp]], [[4zeq]], [[5uuk]], [[5uul]], [[5uup]], [[6e3i]], [[6e3j]], [[6rjp]] - hBcl-2A1 + peptide <br /> |
**[[2vof]] - mBcl-2A1 + Bcl-2 binding component 3 BH3 peptide <br /> | **[[2vof]] - mBcl-2A1 + Bcl-2 binding component 3 BH3 peptide <br /> | ||
**[[2vog]] - mBcl-2A1 + Bmf BH3 peptide <br /> | **[[2vog]] - mBcl-2A1 + Bmf BH3 peptide <br /> | ||
**[[2voh]] - mBcl-2A1 + Bak BH3 peptide <br /> | **[[2voh]] - mBcl-2A1 + Bak BH3 peptide <br /> | ||
**[[2voi]] - mBcl-2A1 + BID BH3 peptide <br /> | **[[2voi]] - mBcl-2A1 + BID BH3 peptide <br /> | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
*Bcl-3 | *Bcl-3 | ||
| Line 74: | Line 82: | ||
*Bcl-6 | *Bcl-6 | ||
| - | **[[3e4u]], [[1r28]], [[1r29]], [[4u2m]] – hBcl-6 BTB domain <br /> | + | **[[3e4u]], [[1r28]], [[1r29]], [[4u2m]], [[6xwf]] – hBcl-6 BTB domain 6-129 <br /> |
**[[3lbz]], [[5mw6]], [[5mw2]], [[5mwd]], [[5n1x]], [[5n1z]], [[5n20]], [[5n21]], [[5x4m]], [[5x4n]], [[5x4o]], [[5x4p]], [[5x9o]], [[5x9p]], [[5x4o]], [[5x4q]], [[6ew8]], [[6ew7]], [[6ew6]], [[6c3n]] – hBcl-6 BTB domain + inhibitor<br /> | **[[3lbz]], [[5mw6]], [[5mw2]], [[5mwd]], [[5n1x]], [[5n1z]], [[5n20]], [[5n21]], [[5x4m]], [[5x4n]], [[5x4o]], [[5x4p]], [[5x9o]], [[5x9p]], [[5x4o]], [[5x4q]], [[6ew8]], [[6ew7]], [[6ew6]], [[6c3n]] – hBcl-6 BTB domain + inhibitor<br /> | ||
**[[6cq1]], [[6c3l]] – hBcl-6 BTB domain (mutant) + inhibitor<br /> | **[[6cq1]], [[6c3l]] – hBcl-6 BTB domain (mutant) + inhibitor<br /> | ||
**[[4cp3]] – hBcl-6 BTB domain + antibiotic<br /> | **[[4cp3]] – hBcl-6 BTB domain + antibiotic<br /> | ||
| + | **[[6xxs]], [[6xyx]], [[6xzz]], [[6zbu]] – hBcl-6 BTB domain + corepressor peptide<br /> | ||
**[[3bim]] – hBcl-6 BTB domain (mutant) + Bcl-6 corepressor<br /> | **[[3bim]] – hBcl-6 BTB domain (mutant) + Bcl-6 corepressor<br /> | ||
**[[5h7g]], [[5h7h]] – hBcl-6 BTB domain + F1324 peptide<br /> | **[[5h7g]], [[5h7h]] – hBcl-6 BTB domain + F1324 peptide<br /> | ||
| Line 89: | Line 98: | ||
*Bcl-9 | *Bcl-9 | ||
| - | **[[3sl9]] – hBcl-9 residues 344-396 + catenin | + | **[[3sl9]] – hBcl-9 residues 344-396 + catenin beta-1<br /> |
| - | **[[2gl7]] – hBcl-9 residues 344-396 + catenin | + | **[[2gl7]] – hBcl-9 residues 344-396 + catenin beta-1 + transcription factor 7-like<br /> |
*Bcl-10 | *Bcl-10 | ||
| Line 109: | Line 118: | ||
**[[4cin]] - hBcl-W + BH3 peptide<br /> | **[[4cin]] - hBcl-W + BH3 peptide<br /> | ||
| - | *Bcl-2-like protein 4 (Bax) | + | *Bcl-2-like protein 4 (Bax or apoptosis regulator Bax) |
**[[4bd7]], [[4s0o]], [[4s0p]] - hBax <br /> | **[[4bd7]], [[4s0o]], [[4s0p]] - hBax <br /> | ||
| - | **[[4bd8]], [[5w60]], [[5w61]] – hBax (mutant) <br /> | + | **[[4bd8]], [[5w60]], [[5w61]], [[6eb6]] – hBax (mutant) <br /> |
| + | **[[6l8v]] - hBax helix2-helix5 - NMR<br /> | ||
**[[2lr1]] - hBax + VMIA peptide<br /> | **[[2lr1]] - hBax + VMIA peptide<br /> | ||
**[[4bd6]] – hBax (mutant) + BH3 peptide<br /> | **[[4bd6]] – hBax (mutant) + BH3 peptide<br /> | ||
| Line 126: | Line 136: | ||
*Bcl-2-like protein 7 (Bak, Bcl-2 homologous antagonist/killer) | *Bcl-2-like protein 7 (Bak, Bcl-2 homologous antagonist/killer) | ||
| - | **[[2yv6]], | + | **[[2yv6]], 2imt, 2jcn, 2ims, [[6odh]], [[7k02]] – hBak<br /> |
**[[5fmi]], [[4u2u]], [[5vx1]] – hBak (mutant)<br /> | **[[5fmi]], [[4u2u]], [[5vx1]] – hBak (mutant)<br /> | ||
**[[4u2v]] – hBak/GFP<br /> | **[[4u2v]] – hBak/GFP<br /> | ||
**[[3qbr]] - hBak + sjA<br /> | **[[3qbr]] - hBak + sjA<br /> | ||
| + | **[[6uxm]], [[6uxn]], [[6uxo]], [[6uxp]], [[6uxq]], [[6uxr]] - hBak + inhibitor<br /> | ||
**[[2xpx]] - hBak fragment + BHRF1<br /> | **[[2xpx]] - hBak fragment + BHRF1<br /> | ||
**[[5vwx]], [[5vwy]], [[5vwz]], [[5vx0]] - hBak + BIM BH3 domain<br /> | **[[5vwx]], [[5vwy]], [[5vwz]], [[5vx0]] - hBak + BIM BH3 domain<br /> | ||
**[[5vwv]] - hBak (mutant)+ BIM BH3 domain<br /> | **[[5vwv]] - hBak (mutant)+ BIM BH3 domain<br /> | ||
**[[2m5b]] - hBak + BID BH3 domain - NMR<br /> | **[[2m5b]] - hBak + BID BH3 domain - NMR<br /> | ||
| + | **[[6mcy]] – mBak<br /> | ||
*Bcl-2-like protein 10 | *Bcl-2-like protein 10 | ||
| - | **[[2kua]] – mBcl-2-L-10<br /> | ||
**[[4b4s]] - hBcl-2-L-10 + hBIM BH3 peptide<br /> | **[[4b4s]] - hBcl-2-L-10 + hBIM BH3 peptide<br /> | ||
| + | **[[2kua]] – mBcl-2-L-10<br /> | ||
| + | **[[6fbx]], [[6h1n]] – Bcl-2-L-10 - zebrafish<br /> | ||
| - | *Bcl-2-like protein 11 ( | + | *Bcl-2-like protein 11 (Bim) |
| - | **[[2nl9]] – | + | **[[2nl9]] – hBim + Mcl-1<br /> |
| + | **[[6x8o]] – hBim BH3 peptide<br /> | ||
| - | + | Mcl-1 (Bcl-2-like protein 3 or Myeloid cell leukemia-1) | |
| - | **[[1wsx]] – mMcl-1 residues 152-308 - NMR<br /> | ||
| - | **[[6dm8]] - mMcl-1/MBP + inhibitor<br /> | ||
**[[3mk8]] - hMcl-1 residues 174-324<br /> | **[[3mk8]] - hMcl-1 residues 174-324<br /> | ||
**[[2mhs]] - hMcl-1 residues 174-324 (mutant)<br /> | **[[2mhs]] - hMcl-1 residues 174-324 (mutant)<br /> | ||
| Line 155: | Line 167: | ||
**[[4wmu]], [[4wmt]] - hMcl-1/MBP (mutant) + ligand<br /> | **[[4wmu]], [[4wmt]] - hMcl-1/MBP (mutant) + ligand<br /> | ||
**[[4wgi]] - hMcl-1/MBP (mutant) + macrolactam<br /> | **[[4wgi]] - hMcl-1/MBP (mutant) + macrolactam<br /> | ||
| - | **[[3wix]], [[3wiy]], [[4oq5]], [[4oq6]], [[4hw2]], [[4hw3]], [[4hw4]], [[4wmr]], [[4zbf]], [[4zbi]], [[5fc4]], [[5fdo]], [[5fdr]], [[5iez]], [[5if4]], [[5jsb]], [[5ku9]], [[5vkc]], [[6b4l]], [[6b4u]], [[6bw2]], [[6bw8]], [[6fs1]], [[6fs2]] - hMcl-1 residues 174-324 + inhibitor<br /> | + | **[[3wix]], [[3wiy]], [[4oq5]], [[4oq6]], [[4hw2]], [[4hw3]], [[4hw4]], [[4wmr]], [[4zbf]], [[4zbi]], [[5fc4]], [[5fdo]], [[5fdr]], [[5iez]], [[5if4]], [[5jsb]], [[5ku9]], [[5vkc]], [[6b4l]], [[6b4u]], [[6bw2]], [[6bw8]], [[6fs1]], [[6fs2]], [[6ne5]], [[6o4u]], [[6o6f]], [[6oqb]], [[6oqc]], [[6oqd]], [[6oqn]], [[6p3p]], [[6qgd]], [[6qfq]], [[6qyp]], [[6qz5]], [[6qz6]], [[6qz8]], [[6qzb]], [[6u63]], [[6u64]], [[6u65]], [[6u67]], [[6u6f]], [[6ud2]], [[6udi]], [[6udt]], [[6udu]], [[6udv]], [[6udx]], [[6udy]], [[6ybg]] - hMcl-1 residues 174-324 + inhibitor<br /> |
| - | **[[ | + | **[[6ovc]] - hMcl-1 residues 174-324 + inhibitor - NMR<br /> |
| - | **[[ | + | **[[6qxj]], [[6qyk]], [[6qyl]], [[6qyn]], [[6qyo]], [[6qz7]], [[6ybj]], [[6ybk]], [[6ybl]] - hMcl-1 residues 174-324/MBP + inhibitor<br /> |
| - | **[[6mbe]] - hMcl-1 residues 174-324 + | + | **[[5c3f]], [[5uum]], [[6mbb]], [[6mbc]], [[6mbd]], [[6mbe]], [[6qfm]], [[6ua3]], [[6uab]] - hMcl-1 residues 174-324 + peptide <br /> |
| - | **[[ | + | **[[6qb3]], [[6qfc]] - hMcl-1 residues 174-324 + scFv <br /> |
| - | **[[ | + | **[[6qb4]] - hMcl-1 residues 174-324 + scFv + inhibitor<br /> |
| + | **[[6qb6]] - hMcl-1 residues 174-324 + antibody <br /> | ||
| + | **[[6zie]] - hMcl-1 residues 174-324 + alphabody <br /> | ||
| + | **[[5mes]], [[5mev]] - hMcl-1 residues 153-221 + inhibitor + antibody<br /> | ||
**[[6fs0]] - hMcl-1 residues 174-324 + inhibitor + antibody<br /> | **[[6fs0]] - hMcl-1 residues 174-324 + inhibitor + antibody<br /> | ||
| + | **[[1wsx]] – mMcl-1 residues 152-308 - NMR<br /> | ||
| + | **[[6dm8]] - mMcl-1/MBP + inhibitor<br /> | ||
*Mcl-1 complex with BH3 domain peptide | *Mcl-1 complex with BH3 domain peptide | ||
| Line 173: | Line 190: | ||
**[[4bpj]], [[4bpi]] - hMcl-1 fragment + Puma BH3 peptide <br /> | **[[4bpj]], [[4bpi]] - hMcl-1 fragment + Puma BH3 peptide <br /> | ||
**[[5c6h]] - hMcl-1 fragment + Mule BH3 peptide <br /> | **[[5c6h]] - hMcl-1 fragment + Mule BH3 peptide <br /> | ||
| - | **[[5w89]], [[5w8f]], | + | **[[5w89]], [[5w8f]], 3kj0, 3kj1, 3kj2, 3io9, 3d7v, 2pqk, [[5vx2]], [[6qfi]] - hMcl-1 fragment + BIM BH3 peptide <br /> |
**[[2kbw]] - hMcl-1 fragment + BID BH3 peptide - NMR <br /> | **[[2kbw]] - hMcl-1 fragment + BID BH3 peptide - NMR <br /> | ||
| Line 186: | Line 203: | ||
**[[2i39]] – VvN1L – Vaccinia virus<br /> | **[[2i39]] – VvN1L – Vaccinia virus<br /> | ||
**[[4bbb]], [[4bbc]], [[4bbd]] – VvN1L (mutant)<br /> | **[[4bbb]], [[4bbc]], [[4bbd]] – VvN1L (mutant)<br /> | ||
| + | |||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 08:20, 2 May 2021
3D structures of B-cell lymphoma proteins
Updated on 02-May-2021
Mcl-1 (Bcl-2-like protein 3 or Myeloid cell leukemia-1)
